Home > Healthcare > Medical Devices > Diagnostic Devices > Specimen Validity Testing Market

Specimen Validity Testing Market Trends

  • Report ID: GMI5863
  • Published Date: May 2023
  • Report Format: PDF

Specimen Validity Testing Market Trends

The increasing incidence of illicit drug abuse is anticipated to contribute to the growth of the specimen validity testing industry. Illicit drug abuse poses significant challenges to public health and safety. For instance, according to the National Survey on Drug Use and Health (NSDUH), in 2021, 52.5 million people globally were estimated to use marijuana, a most commonly used illicit drug. In response, various industries, such as workplaces, law enforcement agencies, and drug rehabilitation programs, have increased their focus on drug testing to ensure safety, compliance, and effective treatment. This increased demand for drug testing creates a parallel need for specimen validity testing to verify the integrity of samples and prevent sample manipulation or adulteration. Additionally, factors such as rising economic conditions, regulatory landscapes, and advancements in drug testing technologies is proving beneficial for the revenue growth.  

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for specimen validity testing was around USD 2.4 billion in 2022 and will reach over USD 4.7 billion by the end of 2032.

Specimen validity testing industry share from the drug screening laboratories segment will record a 6.5% CAGR from 2023-2032 on account of the wide-range availability of advanced detection & screening equipment and services across these labs.

North America specimen validity testing market size will surpass USD 1.9 billion by 2032 due to factors like presence of key market players and an increase in the number of illicit drug use.

Abbott Laboratories, Alfa Scientific Designs, Inc., ACM Global Laboratories, Danaher Corporation, Express Diagnostics, American Bio Medica Corporation, GenomeWeb LLC., LabCorp, Premier Biotech, Inc., Quest Diagnostics Incorporated., and Sciteck, Inc.

Specimen Validity Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 340
  • Countries covered: 30
  • Pages: 180
 Download Free Sample